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ABSTRACT
Ikaros is associated with both gene transcriptional
activation and repression in lymphocytes. Ikaros
acts also as repressor of human c-globin (huc-)
gene transcription in fetal and adult erythroid cells.
Whether andeventually, howIkaros canfunction asa
transcriptional activator in erythroid cells remains
poorlyunderstood.Resultspresentedhereindemon-
strate that Ikaros is a developmental-specific
activator of huc-gene expression in yolk sac eryth-
roid cells. Molecular analysis in primary cells
revealed that Ikaros interacts with Gata-1 and
favors Brg1 recruitment to the human b-globin
Locus Control Region and the huc-promoters,
supporting long-range chromatin interactions
between these regions. Additionally, we demon-
strate that Ikaros contributes to transcription initi-
ation and elongation of the huc-genes, since it is
not only required for TBP and RNA Polymerase II
(Pol II) assembly at the huc-promoters but also for
conversion of Pol II into the elongation-competent
phosphorylated form. In agreement with the latter,
we show that Ikaros interacts with Cyclin-dependent
kinase 9 (Cdk9), which contributes to efficient
transcription elongation by phosphorylating the
C-terminal domain of the large subunit of Pol II on
Serine 2, and favours Cdk9 recruitment to huc-
promoters. Our results show that Ikaros exerts dual
functionality during gene activation, by promoting
efficient transcription initiation and elongation.
INTRODUCTION
The transcription factor Ikaros is widely expressed in
hematopoietic cells where it regulates various aspects of
hematopoiesis (1,2). Ikaros has been associated with gene
activation (3–5), potentiation (6), priming (7) and tran-
scriptional repression (8,9). In proliferating T cells, a
high fraction of Ikaros co-puriﬁes with Mi-2, a core
component of the NuRD complex (10,11). In addition,
Ikaros and Mi-2 control transcriptional regulation of the
Cd4 locus during T cell differentiation (12). Nevertheless,
a signiﬁcant fraction of Ikaros is associated with a
Brg1-based SWI/SNF-like complex (10). The relevance
of the latter interaction has been indicated by several
observations: (i) Ikaros has been associated with gene ac-
tivation mediated by SWI/SNF-like complexes in T cells
(3); (ii) Ikaros co-fractionates and co-immunoprecipitates
with Brg1 (10,13); and (iii) Ikaros and Brg1 are also
components of a SWI/SNF-like complex in mouse
erythroleukemia (MEL) cells (14).
The human b- (hub-) globin locus has been widely used
as a model to explore the effects of transcription factors
and co-factors on tissue- and developmental-speciﬁc gene
expression. The hub-globin locus contains ﬁve develop-
mentally regulated genes (e-
Gg-
Ag-d-b). The locus
control region (bLCR), which is located upstream of the
globin genes, provides high-level globin gene expression in
erythroid cells (EryC). The bLCR is composed of
ﬁve DNase I hypersensitive sites (HSs) which are particu-
larly rich in transcription factor binding sites (15). In EryC
the bLCR favors high-level transcription through close
interaction with gene promoters, and is a major determin-
ant of locus chromatin organization (16). The transcrip-
tion factors EKLF (17), Ikaros (18), BCL11A (19),
GATA-1 and its co-factor FOG-1 (Friend of GATA-1)
(20), as well as the nuclear factor NLI/Ldb1 (21) and
the chromatin remodeling co-regulator Brg1 (22) have
all been shown to be required for efﬁcient long-range chro-
matin interactions between the bLCR and b-like globin
gene promoters.
Beside transcription initiation, modulation of transcrip-
tion elongation is also likely implicated in globin gene
regulation. Indeed, it has been shown that the bLCR
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to elongation for the b major globin (bmaj) gene (23).
Additionally, globin gene expression can be reversibly
inhibited by the ATP analog 5,6-dichloro-1-b-D-
ribofuranosylbenzimidazole (DRB) (24,25), an inhibitor
of cyclin-dependent kinase 9 (Cdk9) (26). Cdk9 is the
catalytic subunit of the positive transcription elongation
factor (P-TEFb). Cdk9 contributes to efﬁcient transcrip-
tion elongation by phosphorylating the C-terminal
domain (CTD) of the large subunit of RNA Polymerase
II (Pol II) on Ser2 (Pol II phospho Ser2). Several
gene-speciﬁc regulators interact with P-TEFb but only a
very limited number of transcription activators have
been shown to recruit it to gene promoters (27).
Two Cdk9 isoforms are found in mammalian cells
and classiﬁed according to apparent molecular weight,
namely Cdk942 and Cdk955. In general Cdk9 is essen-
tial for deﬁnitive but not primitive erythropoiesis
in zebraﬁsh (28), and deregulation of the Cdk9
pathway is implicated in the establishment and/or
maintenance of a transformed cell phenotype, as
documented for a number of human tumors and
lymphomas (26).
Primitive hematopoiesis is the transient production of
large, nucleated erythroid and megakaryocyte progeni-
tors, and takes place in the yolk sac (29). Mouse primitive
EryC express the embryonic globin genes ey and bh1,
whereas the human b-like globin genes expressed at
the same stage of development in transgenic mice
(carrying the complete hub-globin locus) are the embry-
onic e- (hue-) and the fetal g- (hug-) genes (30,31).
Hug-genes are transcriptionally silenced in adult deﬁnitive
EryC by the contribution of several transcription
regulators, such as Gata-1 (32,33), Ikaros (18,34) the
TR2/TR4 heterodimer (35) that are present throughout
primitive as well as deﬁnitive erythropoiesis or the
recently characterized Bcl11a protein, which however
appears to be expressed only in deﬁnitive but not
primitive, yolk sac-derived EryC (30,36). We have
recently shown that Ikaros and Gata-1 cooperate to
silence the hug-genes in EryC at the fetal stage of
development when hug- and hub-genes are expressed
(18). To investigate if Ikaros can also act as transcrip-
tional activator in EryC and to deﬁne the molecular
mechanisms of Ikaros-dependent transcriptional control,
we studied the expression proﬁle of hug-genes in
embryonic day 10.5 (e10.5) yolk sac EryC. We used
line 2 (ln2) mice, which carry a 70 Kb DNA fragment
containing the entire hub-globin locus and express
the human b-like globin genes in a developmental-
speciﬁc manner (31), as well as Ikaros null (Ik
null) mice
that are null for Ikaros proteins due to a deletion in
the last exon that leads to protein instability (37).
Our results reveal that Ikaros is a transcriptional
activator of hug-gene expression in primitive EryC.
We provide the evidence that Ikaros contributes to efﬁ-
cient recruitment of Brg1, Gata-1, Pol II and Cdk9 to
the hug-promoters, thus supporting active chromatin
re-organization, transcription initiation and elongation
of the hug-genes.
MATERIALS AND METHODS
Transgenic mouse lines
All mutant embryos were compared with wild type
littermates, to reduce difference in genetic background
or developmental stage. Embryos were genotyped by
PCR as described in (37). Homozygous ln2 (ln2
+/+) (31):
heterozygous Ikaros (Ik
null+/ ) (37) mice were bred with
ln2
 / :Ik
null+/  females in order to avoid contamination of
embryos with adult blood of the mother, and ln2
+/ :Ik
Wt
(ln2) or ln2
+/ :Ik
null /  (ln2-Ik
null) e10.5 yolk sacs were
isolated. Animals were sacriﬁced by cervical dislocation.
Yolk sacs were rinsed several times with phosphate-
buffered saline (PBS) to remove maternal blood. Blood
was collected by piercing and compressing the yolk sac
with forceps. Animal experiments were conducted in
accordance with the Canadian Council on Animal Care
(CCAC) guidelines and approved by the Maisonneuve-
Rosemont Hospital animal care committee.
Wright-Giemsa staining
This protocol was carried out as previously described (18).
Chromatin immunoprecipitation and quantitative real-time
PCR analyses
Chromatin immunoprecipitation (ChIP) procedure and
quantiﬁcation were as previously described (18) starting
with 5 10
5 e10.5 yolk sac EryC. Cells were ﬁxed with
1% formaldehyde for 10min at 37 C. Chromatin was
reduced in size by sonication in order to obtain fragments
of 400–500bp. About 1/30th of immunoprecipitated and
unbound (input) material was used as template for quan-
titative real-time PCR (qPCR) with SYBR Green
(Invitrogen) on an iCycler iQ
TM (Bio-Rad) system; the
kidney-speciﬁc Tamm-Horsfall gene promoter (Thp) was
used as internal control. All data shown are the results of
at least four independent ChIP experiments with qPCR
reactions from each ChIP performed in triplicate; the
data are plotted as the mean±standard deviation (SD)
of the measurements.
Protein analysis
Western blot (WB) and co-immunoprecipitation (co-IP)
analyses were basically as previously described (18). For
co-IP, 5 10
6 e10.5 yolk sac EryC, 1 10
6 COS-7 cells or
10 10
6 Jurkat cells were lysed in 1ml/10
7 cells of ice-cold
lysis buffer (20mM Hepes pH 8.0, 25% glycerol, 0.2mM
EDTA, 150mM NaCl, 1.5mM MgCl2, 0.5% NP-40) con-
taining protease inhibitors (Protease Inhibitor Cocktail;
Sigma). Where detailed, co-IP washing buffers contained
higher salt (200mM) or NP-40 (1%) concentration. Ikaros
proteins were not detected by WB in yolk sac EryC co-IP
input samples, which represents 2% volume of the total
lysate, i.e.  10
5 yolk sac EryC. Therefore, more
concentrated yolk sac protein lysates, i.e. 2.5 10
6 yolk
sac EryC per lane, were loaded onto SDS–PAGE in
order to identify Ikaros-speciﬁc proteins.
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Cells were transfected with murine Ikaros 2 cDNA, which
is, together with Ikaros-1, the most abundantly expressed
isoform in hematopoietic cells (4) and/or murine Gata-1.
Stable Jurkat cell clones were obtained by retroviral trans-
duction of wild type Jurkat cells with the pOZN-FH-Ik
expression vector (18), which allows expression of Ikaros
in double N-terminally epitope-tagged (Flag and
Hemoagglutinin -FH-) fusion protein. Plasmid character-
istic, cell transfection and selection were carried out as
described in Nakatani et al. (38). COS-7 cells were transi-
ently transfected with Flag/HA Ikaros (pCMV-FH-Ik) or
with Gata-1 (pCMV-Gata) CMV-based expression vector
using the FuGene system (FuGene 6, Roche), according to
the manufacturer’s instructions. Cells were harvested 36h
post-transfection.
Immunoﬂuorescence
For IF studies, transiently transfected COS-7 cells were
seeded on glass slide 24h post-transfection and allowed
to adhere for additional 12h. Cells were then ﬁxed in
4% formaldehyde for 30min at RT, washed once in PBS
and subjected to heat-mediated antigen retrieval treat-
ment. Slides were heated three times to 90 C for 2min
in the retrieval solution (10mM citric acid pH 6.0,
0.05% Tween-20) and then allowed to cool down for
20min at RT. Next, slides were treated with PBS/0.5%
Triton for 20min at RT, washed twice in PBS and
blocked in PBS/0.5% NFDM. Primary (listed in
Supplementary Figure S1) as well as secondary antibodies
(all from Jackson Immunoresearch) were diluted in PBS
containing 0.1% Bovine Serum Albumin and 0.01%
Triton. Slides were dehydrated by treatment with 70, 90
and 100% ethanol and covered with Dapi-Dabco:
Vectashield solution (1:1) in glycerol. Images were
acquired with a LSM 510 META Zeiss confocal micro-
scope with z-resolution of 200mM equipped with Zeiss
LSM Image Browser. Red–green–blue (RGB) proﬁles
were generated by the WCIF ImageJ() program (NIH).
Quantitative reverse transcription–PCR
Total RNA was extracted with Trizol (Invitrogen) and
treated with DNaseI–RNase free (Invitrogen). Reverse
transcription reactions were performed with oligo(dT)15
or random primers and SuperScript III reverse transcript-
ase (Invitrogen). qPCR was carried out on an iCycler
iQ
TM (Bio-Rad) system using speciﬁc primer sets; quanti-
ﬁcation was carried out as previously reported (18). Data
shown are the results of at least ﬁve independent experi-
ments with qPCR reactions from each cDNA performed
in triplicate; the data are expressed as the mean±SD of
the measurements.
Chromosome conformation capture
The chromosome conformation capture (3C) protocol was
basically as previously described (18) using 1–2 10
6 e10.5
yolk sac EryC; data shown are the results of ﬁve independ-
ent experiments with qPCR reactions from each 3C
reaction performed in triplicate; the data are plotted as
the mean±SD of the measurements.
Statistical analysis
Unpaired ‘Student’s t-test’ was used to determine the level
of statistical signiﬁcance (P-value).
Primer sequences and antibodies
Primer sequences and antibodies are published as
Supplementary Figure S1.
RESULTS
Ln2-Ik
null e10.5 yolk sacs do not have gross developmental
defects
Primitive EryC are characterized by their large size and
expression of embryonic b-like globin genes, i.e. ey and
bh1 in mice and e in humans. In transgenic mice carrying
the hub-globin locus (Figure 1A), such as ln2 mice, both
hug- and hue-genes are expressed in yolk sac EryC (30,31).
Ikaros is expressed throughout development in EryC and
can be detected in yolk sac and fetal liver at e11 (2). The
DNA-binding isoforms Ikaros-1, -2/3 and -4 are the
predominant isoforms expressed in hematopoietic cells
(4). To assess the expression pattern of Ikaros isoforms
in yolk sac EryC, total RNA was retro-transcribed and
cDNA ampliﬁed using Ikaros exon 1- and 7-speciﬁc
primers. As shown in Figure 1B, Ikaros-1, -2/3 and -4
isoforms are expressed in yolk sac EryC at a relative
molecular ratio resembling that observed in adult
thymus cells. We then investigated whether erythroid de-
velopment and differentiation are affected in ln2-Ik
null
yolk sac EryC. First, we evaluated yolk sac cellularity.
Keeping in mind the difﬁculties associated with quantita-
tive analysis of e10.5 blood cells, no direct correlation
between Ikaros genotype and total number of nucleated
EryC collected per embryo could be established, suggest-
ing that loss of Ikaros does not generate a quantitative
defect of primitive erythropoiesis; also, ln2-Ik
null
embryos were not visibly anemic, had apparently normal
morphology, and were indistinguishable from wild-type
counterparts (data not shown). Second, we performed
Wright-Giemsa staining of ln2 and ln2-Ik
null yolk sac
EryC. In both genetic backgrounds, embryonic blood
was predominated by large basophilic erythroblasts
(Figure 1C), indicating similar erythroid differentiation
behaviour in ln2 versus ln2-Ik
null yolk sac EryC. Third,
we evaluated transcript levels of the erythrocyte
cell-surface molecule Gpa (Glycophorin A) and the tran-
scription factors Eklf, Gata-1, Fog-1 and Scl/Tal-1, which
are co-regulators critical for erythroid differentiation and
globin gene expression (39). Quantitative reverse
transcription–PCR (qRT–PCR) analysis revealed that
Gpa, Eklf, Gata-1, Fog-1 and Scl/Tal-1 expression levels
do not signiﬁcantly vary between ln2 and ln2-Ik
null yolk
sac EryC (n 4) whereas, as observed in e12.5 fetal liver
EryC (18), loss of Ikaros is associated with increased
Gata-2 levels (Figure 1D; P=0.03). Overall, these
Nucleic Acids Research,2011, Vol.39, No. 9 3507results suggest that loss of Ikaros does not impair yolk sac
EryC development or homeostasis.
Ikaros-dependent huc-globin gene expression in yolk
sac EryC
We have recently shown that Ikaros contributes to
hug-gene transcriptional silencing in e12.5 fetal liver
EryC (18). To investigate the role of Ikaros in globin
gene regulation in yolk sac EryC, levels of hue-, hug-
and hub-gene expression were established by RT–qPCR,
using oligo(dT) primers for cDNA synthesis, intron–exon
junction sequence-speciﬁc primers for qPCR and Actin as
internal control. Loss of Ikaros leads to reduced hug-gene
expression levels in yolk sac EryC (Figure 1D; P=0.005).
Moreover expression of the embryonic hue- and mouse z-,
ey- and bH1-globin genes is unchanged in ln2-Ik
null yolk
sac EryC (n 4), and in these cells we detected only a
slight but signiﬁcant reduction of hub- and mouse bmaj/
bmin globin gene expression (n=6; P 0.05). Similar
results were obtained when Gpa was used as internal
control. For instance, in ln2 versus ln2-Ik
null cells, the
relative level of hug-gene expression was 5.9 (SD 1.2;
n=6; P=0.05). Gpa is an erythroid-speciﬁc membrane
marker gene used as control to ensure that variations in
globin gene expression are not merely due to changes in
the number of viable EryC. Altogether, the above data
suggest that Ikaros speciﬁcally contributes to hug-gene
transcriptional activation in yolk sac EryC.
Ikaros promotes efﬁcient recruitment of Brg1 to bLCR
HS3 and huc-promoters in ln2 yolk sac EryC
It has recently been demonstrated that Ikaros is recruited
to bLCR HS3 (HS3), hug-promoters and a pyrimidine
stretch (Pyr region) located 1 kilobase upstream of the
hud-gene that contributes to hug-gene silencing in
adult-type erythroid cells; however, Ikaros does not bind
to HS2 nor to hue- and hub-promoters even though the
Ikaros consensus sequence, TGGGAA, is found in the
latter [data not shown and (1,14,18,40)]. To investigate
occupancy by Ikaros of these regulatory regions in yolk
sac EryC in vivo, we performed chromatin immunopre-
cipitation (ChIP) analysis using chromatin isolated from
ln2 or ln2-Ik
null yolk sac EryC and Ikaros antibodies (18).
Ikaros is efﬁciently recruited to HS3, hug-promoters and
Pyr region in yolk sac EryC and to CD4 enhancer 1 region
(CD4E1, used as control) in adult thymus cells (12),
whereas no signiﬁcant recruitment was detected at HS2,
hue-o rh u b-promoter (Figure 1E).
Ikaros co-fractionates and co-immunoprecipitates with
Brg1 (10,13,14), and furthermore acts as a potentiator of
gene expression during T-cell development possibly by
recruiting Brg1-containing chromatin remodelling
complexes to appropriate lineage-speciﬁc target genes
(4,6). In addition, Brg1 is recruited to mouse HS3, is
required for embryonic and adult b-globin gene tran-
scription, erythroblast survival (41,42), and long-range
chromatin interactions at the b-globin locus (22).
Therefore, we studied the inﬂuence of Ikaros, when
acting as transcription activator, on long-range chromatin
interactions. As such we exploited the 3C assay to deter-
mine the physical proximity between chromosomal
regions that are normally located many kilobases apart
in vivo. Using the bLCR HS4-HS2 region as ‘ﬁxed’
fragment (43), we observed that long-range chromatin
interactions between the bLCR and the hug-promoters
are decreased in ln2-Ik
null yolk sac EryC (Figure 2A;
n=5; P=0.05). Next, we analyzed in vivo recruitment
of Brg1 to several regions across the hub-globin locus by
ChIP. Brg1 recruitment to HS3 and hug-promoters is
reduced in ln2-Ik
null EryC but is not affected at HS2,
hue-o rh u b-promoters or mouse HS2 and bmaj
Figure 1. Morphological and molecular characterization of ln2 and
ln2-Ik
null yolk sac EryC. (A) Map of the human b-globin locus; black
arrows indicate bLCR HSs; genes are indicated by black boxes; (B)
RT–PCR performed on ln2-Ik
null (Ik
null), ln2 (Ik
WT) yolk sac EryC or
ln2 (Ik
WT) thymus (Th) cells; (C) Wright-Giemsa staining of ln2 or
ln2-Ik
null yolk sac cells; (D) RT–qPCR of hematopoietic as well as
globin gene transcripts performed on equal amounts of ln2 and ln2-
Ik
null yolk sac EryC; transcript quantiﬁcation was calculated according
to Pfafﬂ (73) using mouse Actin cDNA as internal control; ln2/ln2-Ik
null
ratios are plotted as the mean ± SD of the measurements; n   4; (E)
ChIP on ln2 and ln2-Ik
null yolk sac EryC or thymus cells carried out
with Ikaros antibodies; immunoprecipitated and input chromatin
samples were used as template in qPCR; quantiﬁcation was carried
out according to the 2
   Ct method, using mouse kidney-speciﬁc
Tamm-Horsfall protein (Thp) promoter as internal control; fold enrich-
ments (y-axis) of globin regions relative to the control and the input
samples are plotted as the mean±SD of the measurements; a value of
1 (dashed line) indicates no enrichment; *P 0.05 by Student’s t-test;
hue,h u e-promoter; hug,h u g-promoters; hud,h u d-promoter; pyr, Pyr
region; and hub,h u b-promoter; dark gray bars: ln2 yolk sac EryC;
light gray bars: ln2-Ik
null yolk sac EryC; dark gray dashed bars: ln2
thymus cells; light gray dashed bars: ln2-Ik
null thymus cells; white bars:
isotype-matched Ig (Ig ctl).
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Ikaros might inﬂuence Brg1 transcription, we compared
Brg1 expression levels in ln2 and ln2-Ik
null yolk sac EryC
by RT–qPCR and found Brg1 transcription to be essen-
tially unchanged in the two backgrounds (Figure 2C).
Next, we tested whether Ikaros co-immunoprecipitates
with Brg1 in yolk sac EryC by protein co-IP assay. Brg1
is immunoprecipitated and recognized by Brg1 antibodies
by WB; additionally, Ikaros is detected upon Brg1 IP,
thus indicating that Ikaros and Brg1 proteins
co-immunoprecipitate in these cells (Figure 2D).
Ikaros is also known to interact with the nucleosome
remodelling ATPase Mi-2 (a subunit of the NuRD
chromatin remodeling complex) (10,11), and recruits this
co-factor to speciﬁc chromatin regions (18). Even though
Mi-2 is widely perceived as a transcriptional repressor, the
Mi-2-NuRD complex has recently been linked to both
gene activation and repression in the case of certain
Gata-1/Fog-1 target genes (44). For this reason, we
investigated in vivo recruitment of Mi-2 to the hub-globin
locus in ln2 as well as ln2-Ik
null yolk sac EryC by ChIP. As
depicted in Figure 2E, no signiﬁcant recruitment of Mi-2
either to HS3, HS2 or to hue-, hug- and hub-promoters
could be detected. Nonetheless under the same experimen-
tal conditions, in conﬁrming the technical feasibility of
Mi-2 ChIP, we could demonstrate efﬁcient Mi-2 recruit-
ment to the  2.8kb region upstream of the Gata-2
promoter in yolk sac EryC (Figure 2E) (45), the CD4E1
region (12) in freshly-isolated thymic cells (Figure 2E), and
several regions of the hub-globin locus in EryC isolated
from e12.5 fetal livers (18). Due to the possibility that
absence of signiﬁcant Mi-2 recruitment to critical regula-
tory regions of the hub-globin locus might depend upon
lower levels of Mi-2 expression in ln2-Ik
null yolk sac EryC,
we next examined Mi-2 gene expression by RT–qPCR. We
observed that Mi-2 expression levels are the same in ln2
Figure 2. Brg1 and Mi-2 recruitment to the hub-globin locus in ln2
and ln2-Ik
null yolk sac EryC. (A) Ln2 and ln2-Ik
null yolk sac EryC
were subjected to 3C assay; nuclei were digested with EcoRI and
genomic DNA was ligated and used as template for qPCR; bLCR
HS4-HS2 EcoRI fragment was used as ‘ﬁxed’ point and primer sets
were designed in order to amplify the genomic regions corresponding
to the e, e-gene; ie-g, inter-e-g region;
Ag,
Ag-gene and b-gene region;
relative crosslinking frequencies (y-axis) of the ‘ﬁxed’ fragment with
globin fragments were deﬁned using naked DNA encompassing the
whole hub-globin as control and normalized to endogenous mouse
Actin; a value of 1 was attributed to the highest crosslinking frequency;
the data are plotted as the mean±SD of the measurements of ﬁve
independent experiments; x-axis: position across the locus; rhomboids:
ln2 yolk sac EryC; squares: ln2-Ik
null yolk sac EryC; triangles: brain
cells; (B and E) ChIP on ln2 and ln2-Ik
null yolk sac EryC or thymus
cells carried out with Brg1 or Mi-2 antibodies; fold enrichments (y-axis)
were calculated as described in Figure 1E and are plotted as the
mean±SD of the measurements; a value of 1 (dashed line) indicates
no enrichment; *P 0.05 by Student’s t-test; hue,h u e-promoter; hug,
hug-promoters; pyr, Pyr region; hub,h u b-promoter; m2, mouse HS2;
bmaj, bmajor promoter;  2.8:  2.8kb region upstream of the Gata-2
promoter and CD4E1: CD4 enhancer 1 region; dark gray bars: ln2 yolk
sac EryC; light gray bars: ln2-Ik
null yolk sac EryC; dark gray dashed
bars: ln2 thymus cells; light gray dashed bars: ln2-Ik
null thymus cells;
white bars: isotype-matched Ig (Ig ctl); (C and F) RT–qPCR of Brg1
and Mi-2 gene transcripts performed on equal amounts of ln2 and ln2-
Ik
null yolk sac EryC; transcript quantiﬁcation was calculated according
to Pfafﬂ (73) using mouse Actin cDNA as internal control; ln2/ln2-Ik
null
ratios are plotted as the mean±SD of the measurements; n=6; (D
and G) Protein co-IP of total cell lysates prepared from ln2 yolk sac
EryC; cell lysates were immunoprecipitated with Mi-2 or Brg1
antibodies as well as isotype-matched Ig; samples were resolved on
SDS–PAGE, immunoblotted and WB membranes were cut in half;
the higher half was probed with either Mi-2 or Brg1 antibodies,
whereas the lower half was probed with Ikaros antibodies; asterisks
indicate non-speciﬁc bands; WCE: yolk sac EryC total cell lysate.
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null yolk sac EryC (Figure 2F). However, under
the same stringency conditions that allowed co-IP of
Ikaros and Brg1 (150mM NaCl, 0.5% NP-40), Ikaros
and Mi-2 could not be co-immunoprecipitated in yolk
sac EryC with speciﬁc antibodies (Figure 2G). These
results argue against a direct role of Mi-2 for hug-gene
activation in yolk sac EryC, and rather suggest that
Ikaros-dependent recruitment of Brg1 to hug-promoters
and HS3 is required for efﬁcient hug-gene expression in
these cells.
Ikaros facilitates Gata-1 recruitment to huc-regulatory
regions in yolk sac EryC
We previously reported that Ikaros physically interacts
with Gata-1 and facilitates Gata-1 recruitment to HS3
and hug-promoters in e12.5 fetal liver EryC (18). To
better deﬁne Ikaros-Gata-1 protein interaction, we ﬁrst
analyzed the subcellular localization of Ikaros and
Gata-1 at the single-cell level by immunoﬂuorescence
(IF) and confocal microscopy. COS-7 cells, which lack
any Ikaros or Gata-1 protein, were transfected with
Flag/HA-Ikaros (pCMV-FH-Ik) together with Gata-1
(pCMV-Gata) expression vectors, ﬁxed with formalde-
hyde, permeabilized and immunolabeled with antibodies
speciﬁc for HA (i.e. Ikaros detection) or Gata-1. Ikaros
and Gata-1 were detected using secondary antibodies
conjugated to Texas red (TR) or Fluorescein isothiocyan-
ate (FITC) ﬂuorochromes, respectively. The use of
cross-absorbed and afﬁnity-puriﬁed secondary antibodies
minimized background and non-speciﬁc reactivity to
undetectable ﬂuorescent levels (data not shown).
Confocal microscopy analysis revealed that both Ikaros
(red signals) and Gata-1 (green signals) have a dominant
nuclear localization (Figure 3A), whereas COS-7 cells
transfected with empty vectors (mock control) showed un-
detectable levels of green or red stain (Supplementary
Figure S2A). Interestingly, the merged image obtained in
COS-7 cells that express both Ikaros and Gata-1, leads to
the emergence of several yellow nuclear signals per focal
plane (Figure 3A). Physical overlap between Ikaros and
Gata-1 was further deﬁned by the ImageJ()program,
which revealed that the line proﬁle plots and ﬂuorescent
peaks of Ikaros and Gata-1 often overlap whereas the
ﬂuorescence proﬁles of Ikaros and Ape1, a nuclear
protein that does not interact with Ikaros used as
negative control (46), are discordant.
Next, Ikaros-Gata-1 protein interaction was
investigated by protein co-IP. Protein lysates of ln2 yolk
sac EryC were immunoprecipitated with Ikaros or Gata-1
antibodies as well as isotype-matched rabbit (for Ikaros
co-IP) or rat (for Gata-1 co-IP) immunoglobulins (Ig) and
immunoblots were probed with Ikaros antibodies. The
results show that Ikaros can be immunoprecipitated by
Gata-1 antibodies but not by control Ig (Figure 3B),
suggesting that Ikaros and Gata-1 can be part of the
same protein complex also in yolk sac EryC.
Ikaros-Gata-1 cooperative binding to the hub-globin
locus was then investigated by ChIP. In ln2-Ik
null yolk
sac EryC, Gata-1 binding is diminished at hug-promoters
and Pyr region whereas is normal at HS3 and HS2
(Figure 3C). In order to investigate whether loss of
Ikaros speciﬁcally decreases Gata-1 binding or induces a
more general alteration of transcription factor recruit-
ment, we analyzed p45/Nf-e2 and Yy1occupancy since
these proteins bind to hug-promoters. No signiﬁcant
difference in p45/Nf-e2 (Figure 4A) or Yy1 (Figure 4B)
recruitment was detected at tested chromatin regions in
ln2 versus ln2-Ik
null yolk sac EryC. We then examined
whether the Ikaros-Gata-1 complex could modulate
recruitment of the Gata-speciﬁc cofactor Fog-1 by ChIP.
Fog-1 is recruited to HS3, HS2, hug- and hub-promoters
in ln2 and, unexpectedly, ln2-Ik
null yolk sac EryC
(Figure 4C), even though Gata-1 binding to these pro-
moters is close to background levels (Figure 3C). This
outcome suggests that Fog-1 recruitment to hug- and
hub-promoters in ln2-Ik
null cells does not depend solely
on Gata-1. Since Gata-1 and Gata-2 (i) bind to the same
DNA motifs in vivo and in vitro (47–49); (ii) function re-
dundantly to promote primitive erythroblast development
(50); (iii) exert their respective functions in a dose-
dependent fashion (39,51); and (iv) bind Fog-1 protein
(52), we set out to investigate Gata-2 occupancy at
globin promoters in ln2-Ik
null EryC. Loss of Ikaros correl-
ates with increased Gata-2 recruitment to HS2, hug- and
hub-promoters, whereas Gata-2 recruitment does not sig-
niﬁcantly change at the Gpa promoter, which was used as
a control for Gata-2 binding (Figure 4D) (53). These
results suggest that Ikaros contributes to Gata-1 binding
at hug-promoters and Pyr region in ln2 yolk sac EryC.
They also indicate that increased Gata-2/Gata-1 ratio, as
observed in absence of Ikaros (Figure 1D), might enhance
the interaction between Fog-1 and Gata-2, thus allowing
Gata-2 to efﬁciently support Fog-1 recruitment to
hug-promoters in yolk sac EryC.
Ikaros contributes to efﬁcient PIC assembly and
transcription elongation of huc-promoters in
ln2 yolk sac EryC
A critical step during eukaryotic gene transcription is the
assembly of the PIC consisting of Pol II and general tran-
scription factors (27). Both chromatin conformation and
gene-speciﬁc activators inﬂuence PIC assembly and hence,
transcriptional efﬁciency. We proceeded to deﬁne Ikaros
contribution to PIC assembly at the hug-promoters by
ChIP. As expected, TBP and Pol II were each efﬁciently
detected at hue- and hug-promoters in ln2 yolk sac EryC;
in ln2-Ik
null cells, TBP and Pol II recruitment is affected at
hug- but not hue-or Gpa-promoters and Pol II recruitment
is also diminished at the HS2 region in ln2-Ik
null yolk sac
EryC (Figure 5A and B). Since Pol II recruitment to
hug-promoters is only moderately affected by loss of
Ikaros, we examined whether Ikaros could also control
the efﬁciency of transcription elongation by studying: (i)
levels of Pol II phospho Ser2 (PCTD) recruitment to the
hug-genes, because it is known that the levels of this
phosphorylated residue is required and increase during
transcription elongation (27); (ii) the relative levels of
hug-globin 50- and 30-primary transcripts, because
primary transcript levels accurately reﬂect the rate of tran-
scription. ChIP assays revealed that PCTD recruitment to
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affected in absence of Ikaros (Figure 5C). Primary
transcript expression was determined by RT–qPCR
using random primers for cDNA synthesis and hug-gene
and mouse Gapdh intronic sequence-speciﬁc primers for
qPCR. In line with reduced PCTD occupancy at hug
regions, there was an accumulation of transcripts corres-
ponding to the 50-end of the gene and signiﬁcant reduction
of full-length transcripts (Figure 5D). These results are
reminiscent of a gene that initiates transcription without
completing elongation, thus supporting a possible role of
Ikaros during productive hug-gene transcription
elongation.
Ikaros interacts with Cdk9
In higher eukaryotes, Pol II Ser2 phosphorylation is
mediated primarily by the Cdk9 catalytic subunit of the
P-TEFb complex (27). Considering that the Cdk9 inhibi-
tor DRB is known to affect transcription elongation of
hug-genes (24,25), we investigated whether the P-TEFb
complex is involved in hug-gene transcription elongation
and whether Ikaros inﬂuences the recruitment of P-TEFb
to the hug-genes. Interestingly, ChIP revealed that Cdk9 is
recruited to hue- and hug-promoters in ln2 yolk sac EryC,
and that Cdk9 occupancy is signiﬁcantly reduced at
hug- but not hue-promoters is in ln2-Ik
null yolk sac
EryC (Figure 6A). To evaluate the signiﬁcance of the
3-fold enrichment observed in ln2 EryC, we performed
ChIP with Cdk9 antibodies in DMSO-induced MEL
cells since it has recently been shown that Cdk9 is re-
cruited to the bmaj promoter in these cells (54). The
level of Cdk9 enrichment at bmaj promoter in MEL
cells is very similar to the occupancy levels of Cdk9 at
hug-promoters in ln2 yolk sac EryC, thus conﬁrming the
Figure 3. Ikaros-Gata-1 cooperative binding. (A) Confocal immunoﬂuorescence of COS-7 cells expressing Flag/HA-Ikaros and Gata-1 proteins
(Ikaros+Gata-1) or Flag/HA-Ikaros only (Ikaros); Ikaros+Gata-1 transfected cells were stained with mouse antibodies to the HA tag and with rat
antibodies to Gata-1; the secondary staining was carried out with TR-conjugated anti-mouse as well as FITC-conjugated anti-rat antibodies; a single
COS-7 cell is shown where Ikaros is detected as red signals, Gata-1 as green signals and Ikaros-Gata-1 co-localization as yellow signals in the
magniﬁed merged image; Ikaros-transfected cells were stained with rabbit antibodies to the HA tag and with mouse antibodies to Ape1; the
secondary staining was carried out with FITC-conjugated anti-rabbit as well as TR-conjugated anti-mouse antibodies; a single COS-7 cell is
shown where Ikaros is detected as green signals and Ape1 as red signals; line proﬁle plots were obtained by the WCIF ImageJ() program
(NIH); (B) Protein co-IP of total cell lysates prepared from ln2 yolk sac EryC; cell lysates were immunoprecipitated with Ikaros or Gata-1 antibodies
as well as isotype-matched rabbit (for Ikaros co-IP) or rat (for Gata-1 co-IP) Ig and WB was carried out with Ikaros antibodies; ﬁlled circles
represent Ig bands; asterisks indicate non-speciﬁc bands; WCE: yolk sac EryC total cell lysate; (C) ChIP on ln2 and ln2-Ik
null yolk sac EryC carried
out with Gata-1 antibodies; fold enrichments (y-axis) were calculated as described in Figure 1E and are plotted as the mean±SD of the measure-
ments; a value of 1 (dashed line) indicates no enrichment; *P 0.05 by Student’s t-test; hue,h u e-promoter; hug,h u g-promoters; pyr, Pyr region; hub,
hub-promoter; m2, mouse HS2; dark gray bars: ln2 yolk sac EryC; light gray bars: ln2-Ik
null yolk sac EryC; white bars: isotype-matched Ig (Ig ctl).
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Importantly, loss of Ikaros does not modulate the level of
Cdk9 transcripts (Figure 6B) or proteins (Figure 6C) in
yolk sac EryC.
Cdk9 interacts with a number of transcription factors
(27). To investigate whether Ikaros and Cdk9 interact in
yolk sac EryC, we performed protein co-IP with Cdk9
antibodies or control Ig. Immunoblots probed with
Ikaros antibodies revealed that Ikaros can be immunopre-
cipitated by Cdk9 antibodies but not by control Ig, hence
suggesting that these proteins physically interact
(Figure 6D). To assess Ikaros-Cdk9 interaction at
single-cell level, we analyzed the subcellular localization
of these proteins by IF and deconvolution microscopy
Figure 5. PIC assembly at hug-genes in ln2 and ln2-Ik
null yolk sac
EryC. (A–C) ChIP on ln2 and ln2-Ik
null yolk sac EryC carried out
with TBP, Pol II and Pol II phospho Ser2 (PCTD) antibodies; fold
enrichments (y-axis) were calculated as described in Figure 1E and are
plotted as the mean±SD of the measurements; a value of 1 (dashed
line) indicates no enrichment; *P 0.05 by Student’s t-test; hue,
hue-promoter; hug,h u g-promoters; hugg, hug-genes; hub,
hub-promoter; Gpa, Glycophorin A promoter; dark gray bars: ln2
yolk sac EryC; light gray bars: ln2-Ik
null yolk sac EryC; white bars:
isotype-matched Ig (Ig ctl); (D) RT–qPCR of hug-gene 50- and
30-primary transcripts performed on equal amounts of ln2 and ln2-
Ik
null yolk sac EryC using random primers for cDNA synthesis; tran-
script quantiﬁcation was calculated according to Pfafﬂ (73) using the
hug-globin speciﬁc primer sets (Pr) depicted as colored bars and mouse
Gapdh primary transcripts as internal control; ratios are plotted as the
mean±SD of the measurements; n 3; P 0.05; Ex: indicates the
three exons of the hug-gene.
Figure 4. Recruitment of transcriptional regulators to the hub-globin
locus in yolk sac EryC. (A–D) ChIP on ln2 and ln2-Ik
null yolk sac EryC
carried out with p45/Nf-e2 (p45), Yy1, Fog-1 and Gata-2 antibodies;
fold enrichments (y-axis) were calculated as described in Figure 1E and
are plotted as the mean±SD of the measurements; a value of 1
(dashed line) indicates no enrichment; *P 0.05 by Student’s t-test;
hue,h u e-promoter; hug,h u g-promoters; hub,h u b-promoter; m2,
mouse HS2; Gpa, Glycophorin A promoter; dark gray bars: ln2 yolk
sac EryC; light gray bars: ln2-Ik
null yolk sac EryC; white bars:
isotype-matched Ig (Ig ctl).
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protein were ﬁxed with formaldehyde, permeabilized and
immunolabeled with antibodies speciﬁc for HA (i.e. Ikaros
detection) or Cdk9. Ikaros and Cdk9 were detected using
secondary antibodies conjugated to FITC or TR ﬂuoro-
chromes, respectively. COS-7 cells transfected with the
empty vector (mock control) showed undetectable levels
of green stain (Supplementary Figure S2B). Confocal mi-
croscopy analysis revealed that both Ikaros (green signals)
and Cdk9 (red signals) are distributed throughout the
nucleus and that these proteins signiﬁcantly overlap,
even though they do not colocalize at each and every
nuclear sites, in accordance with known evidence that
Cdk9 is present in several other protein complexes (26).
Since Ikaros is known to act as transcriptional repressor
and activator of speciﬁc genes in T lymphocytes, it was
intriguing to know whether Ikaros could possibly interact
with Cdk9 in the T lymphocyte-like Jurkat cell line. Jurkat
cells were stably transfected with the pOZN-FH-Ik expres-
sion vector that contains a bicistronic transcriptional unit,
which allows expression of two proteins from a single
transcript. This design ensures tight coupling between
expression of the gene of interest and the selection
marker, the interleukin-2 receptor a chain (IL2Ra)
(18,38). Three rounds of magnetic afﬁnity sorting with
antibodies against the IL-2a receptor were sufﬁcient to
obtain a pure population of Jurkat cells (namely, Ju/Ik
clone) that express Flag/HA-Ikaros at lower levels than
endogenous Ikaros (Figure 7A). Total cell lysates were
immunoprecipitated with Flag, Cdk9 antibodies or
control Ig and WB performed with HA or Cdk9
antibodies. As shown in Figure 7B, Flag/HA-Ikaros is
immunoprecipitated by both Flag and Cdk9 antibodies.
As well, Cdk9 is immunoprecipitated by both Flag and
Cdk9 antibodies, indicating that Ikaros and Cdk9 are
part of the same protein complex. These results suggest
that the Ikaros-Cdk9 interaction can also occur in
lymphoid cells and does not require Ikaros overexpression
because Flag/HA-Ikaros is expressed at lower levels than
endogenous Ikaros.
Since Ikaros interacts with Gata-1 (18) (Figure 3B), and
Gata-1 has been shown to interact with the P-TEFb
component Cyclin T1 (CycT1) in megakaryocytes (55),
we sought to investigate whether Gata-1 could interact
with Cdk9 in mouse erythroleukemic MEL cells. Protein
co-IP revealed that Cdk9 can be efﬁciently immunopre-
cipitated by one out of two antibodies tested directed
against Gata-1 (clone M20) and that Gata-1 is
immunoprecipitated, even though weakly, by Cdk9
antibodies (Figure 7C), thus indicating that Gata-1 and
Cdk9 are part of the same protein complex in MEL
cells. Next, we asked whether Gata-1 could either interfere
with or enhance the interaction between Ikaros and Cdk9.
To this end, COS-7 cells were transfected with pCMV-
FH-Ik, pCMV-Gata-1 or pCMV-FH-Ik together with
pCMV-Gata-1 expression plasmid. Cell lysates were
immunoprecipitated with Gata-1 (N6 as well as M20
clone), Cdk9, Flag antibodies or control Ig and
precipitated proteins were analyzed by WB with Cdk9,
HA or Gata-1 antibodies. As expected, Ikaros and
Gata-1 interact in COS-7 transfected cells that express
both proteins, as revealed by Gata-1 co-IP and WB
Figure 6. Ikaros-mediated recruitment of Cdk9 to the hug-genes in yolk sac EryC. (A) ChIP on ln2 and ln2-Ik
null yolk sac EryC carried out with
Cdk9 antibodies; fold enrichments (y-axis) were calculated as described in Figure 1E and are plotted as the mean±SD of the measurements; a value
of 1 (dashed line) indicates no enrichment; *P 0.05 by Student’s t-test; hue,h u e-promoter; hug,h u g-promoters; hub,h u b-promoter; bma, bmajor
promoter; dark gray bars: ln2 yolk sac EryC; light gray bars: ln2-Ik
null yolk sac EryC; dark gray dashed bars: MEL cells; white bars: isotype-matched
Ig (Ig ctl); (B) RT–qPCR of Cdk9 gene transcripts performed on equal amounts of ln2 and ln2-Ik
null yolk sac EryC; transcript quantiﬁcation was
calculated according to Pfafﬂ (73) using mouse Actin cDNA as internal control; ln2/ln2-Ik
null ratios are plotted as the mean±SD of the measure-
ments; n=6; (C) WB performed on total cell lysates prepared from wild type or Ik
null yolk sac EryC with Cdk9 or Actin antibodies; (D) protein
co-IP of total cell lysates prepared from ln2 yolk sac EryC; cell lysates were immunoprecipitated with Cdk9 antibodies or isotype-matched Ig and
WB were carried out with Ikaros antibodies; WCE: yolk sac EryC total cell lysate; (E) Confocal immunoﬂuorescence of COS-7 cells expressing Flag/
HA-Ikaros protein; cells were stained with mouse antibodies to the HA tag and with rabbit antibodies to Cdk9; the secondary staining was carried
out with FITC-conjugated anti-mouse as well as TR-conjugated anti-rabbit antibodies; a single COS-7 cell is shown where Ikaros is detected as green
signals, Cdk9 as red signals, and Ikaros-Cdk9 co-localization as yellow signals in the magniﬁed merged image; line proﬁle plots of Ikaros (in green)
and Cdk9 (in red) were obtained by the WCIF ImageJ() program (NIH).
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panel). However, in COS-7 cells that express either
Gata-1 or Gata-1 together with Flag/HA-Ikaros, Gata-1
is not detected upon Cdk9 co-IP nor is Cdk9 detected
upon Gata-1 co-IP (Figure 7D), thus suggesting that
Gata-1 and Cdk9 do not stably interact in
non-hematopoietic, COS-7 cells. Using the same trans-
fected cells and under the same stringency conditions,
Flag/HA-Ikaros is detected upon Cdk9 co-IP and Cdk9
is detected upon Flag co-IP (Figure 7D and E), indicating
that Ikaros and Cdk9 co-immunoprecipitate also in
COS-7 cells and that additional hematopoietic-speciﬁc
proteins are not required for this interaction. It is to
notice that the interaction between Ikaros and Cdk9 can
be maintained at higher stringency conditions, i.e. 200mM
NaCl or 1% NP-40 (Supplementary Figure S3A).
Interestingly, Gata-1 appears to increase the degree of
Ikaros-Cdk9 interaction, since the intensity of the
immunoprecipitated bands is proportional to the levels
of Gata-1 expression (Figure 7E). Altogether, these data
indicate that (i) Ikaros and Gata-1 interact also in COS-7
transfected cells; (ii) Gata-1 interacts with Cdk9 in eryth-
roid cells; (iii) Ikaros interacts with Cdk9 in erythroid,
lymphoid as well as COS-7 transfected cells; and (iv)
Ikaros-Cdk9 interaction does not require Gata-1 even
though Gata-1 appears to enhance the strength of this
interaction.
DISCUSSION
In the present study, we have shown that Ikaros acts as
a stage-speciﬁc activator of hug-genes in yolk sac EryC
by (i) favoring Brg1 and Gata-1 recruitment to hug-
promoters and contributing to chromatin interaction
between the bLCR and these promoters and (ii) support-
ing efﬁcient PIC assembly and Cdk9 recruitment to
hug-promoters and hence, Pol II Ser2 phosphorylation
which is required for transcription elongation. This
suggests that through combined action with transcription
factor and co-factor partners, Ikaros can exert control
over both transcription initiation and elongation.
Figure 7. Ikaros interacts with Cdk9 in Jurkat and COS-7 cell lines. (A) WB performed on total cell lysates prepared from Jurkat cells (Ju) or Jurkat
cells stably transfected with the pOZN-FH-Ik expression vector (Ju/Ik); endogenous (Ik) as well as double Flag/HA-Ikaros-speciﬁc bands (FH-Ik)
are indicated; (B) Protein co-IP of total cell lysates prepared from Ju/Ik cells; ﬁlled circles represent Ig bands; WCE: Ju/Ik total cell lysate; (C)
Protein co-IP of total cell lysates prepared from MEL cells; I, Input; M20, anti-Gata-1 antibodies, clone M20; N6, anti-Gata-1 antibodies, cloneN6;
Ig, isotype-matched Ig; (D and E) Protein co-IP of total cell lysates prepared from COS-7 cells transfected (Tr) with empty vector (mock, M), Flag/
HA-Ikaros (Ik), Gata-1 (G1) or Flag/HA-Ikaros together with Gata-1 (G/Ik); antibodies used for protein co-IP (IP) and WB are indicated on each
panel; I, Input; M20, anti-Gata-1 antibodies, clone M20; N6, anti-Gata-1 antibodies, cloneN6; ﬁlled circles represent Ig bands.
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Previous analysis of Ik
null mice highlighted the importance
of Ikaros for the regulation of hematopoietic genes (7). In
particular Scl/Tal-1, Flk-2 receptor and c-kit receptor gene
expression is affected in Ik
null bone marrow hematopoietic
stem cells (HSC) (56). However, in Ik
null fetal liver EryC,
Scl/Tal-1 expression levels are unchanged, whereas Eklf
and Gata-2 expression levels are, respectively, decreased
and increased (18,34). Finally, in Ik
null yolk sac EryC,
we report that Eklf, Gata-1, Fog-1 and Scl/Tal-1 expres-
sion levels are unchanged, whereas Gata-2 is over-
expressed. Therefore, Ikaros, likely in association with
speciﬁc chromatin regulators, can activate or repress a
variety of hematopoietic-speciﬁc genes in a cell type- and
developmental stage-speciﬁc manner.
Ikaros is essential for speciﬁcation in lymphoid lineages,
and inactivation of this protein exerts a profound effect on
the production and differentiation of fetal lymphocyte
progenitors (37). However, recent studies have identiﬁed
Ikaros as an important regulator of lympho-myeloid
lineage decisions in early hematopoietic progenitor cells
(7). Ikaros can also inﬂuence erythroid cell differentiation.
For example, adult Ik
null mice display extramedullary
hematopoiesis, bone marrow hypoplasia, and slight reduc-
tion in the number of BFU-E (Burst-Forming Unit
Erythroid) and CFU-E (Colony-Forming Unit
Erythroid) progenitors; however, reduced CFU-E and
BFU-E activity is reported to be mainly due to a deﬁcit
in the HSC population rather than aberrant erythroid dif-
ferentiation (56). Accordingly, erythropoiesis appears to
be normal at earlier stages of development in fetal liver
(18,37) and yolk sac (this work) isolated from Ik
null mice
where erythroid differentiation progresses to the point of
producing Gpa transcripts, normal numbers of maturing
proerythroblasts and typical levels of murine globin gene
transcripts. Based on these ﬁndings, we conclude that
reduced levels of hug-gene expression in ln2-Ik
null cells is
not the consequence of impaired erythroid differentiation
or maturation, and hence that Ikaros is recruited to, and
directly contributes to regulation of, the hug-genes in yolk
sac EryC.
Ikaros, Brg1 and Gata-1 cooperate to control huc-gene
expression in yolk sac EryC
We have recently shown that Ikaros participates to
hug-gene silencing at the time of g-to-b globin switching
which takes place at  e12 in transgenic ln2 fetal liver
by targeting a Gata-1/Fog-1/Hdac1/Mi-2-containing
multiprotein complex to hug-promoters (18). Here, we
have shown that Ikaros, along with Gata-1 and Brg1,
rather contributes to hug-gene expression at an earlier
developmental stage, i.e. in e10.5 yolk sac EryC.
The observation that Ikaros can act as transcription acti-
vator and repressor for the same gene in a stage- and
cell-speciﬁc manner is reminiscent of previous studies
showing that Ikaros represses Il4 expression in mast cells
(57), but activates that gene in Th2 cells, and also appears
to exert distinct effects on Il4 and Ifn gene expression in
the same cell type (Th1 and Th2) (58). The ability of
Ikaros to preferentially interact with Mi-2, Brg1 or other
known Ikaros co-regulators, and hence, to direct them to
distinct gene regulatory regions, might depend on Ikaros
post-translational modiﬁcations. Indeed, sumoylated
Ikaros preferentially interacts with Brg1 versus Mi-2
(13). Thus, increased sumoylation levels in yolk sac
relative to fetal liver EryC could account for the
tendency of Ikaros to interact with Brg1, and possibly
act as transcription activator. This could not be directly
addressed since sumoylation is a highly dynamic process
and a suitable cellular model for human primitive EryC is
currently unavailable. A second, non-mutually exclusive
explanation for different levels of Ikaros interaction with
Mi-2 versus Brg1 is that expression of these co-regulators
might ﬂuctuate during development. In accordance with
such hypothesis, we observed that Brg1 is expressed at
higher levels in yolk sac than fetal liver EryC, whereas
Mi-2 expression is higher in fetal liver EryC
(Supplementary Figure S3B). Brg1 is the principal catalyt-
ic subunit of a SWI/SNF-like complex in Ter119
+ EryC,
and is essential for viability in mice (59). The use of
hypomorphic (41) and conditional Brg1
null mutations
(42) have demonstrated that Brg1 is required for chroma-
tin remodelling during both embryonic and adult b-globin
gene transcription, and for maximal Pol II occupancy at
the mouse bmaj promoter (60). A number of transcription
factors are known to bind and recruit Brg1 to the globin
locus (40,61–63); nonetheless using a Gata-1-inducible cell
line, Kim et al. (22) reported that Gata-1 recruits Brg1 to
the adult bmaj promoter more rapidly than other
transcription factors tested.
The current results, together with previous published
data (18), indicate that Gata-1 is a relevant Ikaros-
interacting transcription factor and their combined effect
is required for globin gene regulation in EryC. Indeed,
Gata-1 and Ikaros are recruited in vivo to the hub-globin
locus, inﬂuence long-range chromatin interactions, con-
tribute to hug-gene regulation and co-immunoprecipitate
in vivo in primary yolk sac (herein) and fetal liver (18)
EryC. Gata-1 has been associated to both hug-gene acti-
vation and repression, depending on the experimental
model. For instance, Gata-1 contributes to hug-gene
silencing at the time of g-to-b globin switching in mouse
fetal liver (18) or in adult (32,33) EryC. By cooperating
with BCL11a and SOX6, GATA-1 has recently been
shown to contribute to hug-gene silencing in adult
human erythroid progenitors (19) and interestingly,
Bcl11a is not expressed either in wild-type (30) or Ik
null
primitive EryC (Supplementary Figure S3C). However,
GATA-1 has also been associated with hug-gene activa-
tion (64). Finally GATA-1 overexpression in K562 cells
does not change hug-gene expression (65).
Despite the fact that Ikaros does not affect Gata-1
occupancy at bLCR HS2, recruitment of Gata-2 and Pol
II to this region is signiﬁcantly increased and decreased,
respectively, in ln2-Ik
null yolk sac EryC. It has recently
been reported that Gata-1 occupancy at the well-deﬁned
 1.8kb site of the Gata-2 locus is associated with Pol II
expulsion and stable gene repression (66). Therefore, it is
possible that, similarly to Gata-1 at the  1.8kb site of the
Gata-2 locus, increased Gata-2 occupancy at bLCR HS2
Nucleic Acids Research,2011, Vol.39, No. 9 3515of the hub-globin locus could partially display Pol II at
this distal regulatory element.
In conclusion, even though we cannot exclude that
Ikaros may also facilitate hug-gene expression indirectly,
e.g. by contributing to Gata-2 gene repression in yolk sac
EryC, our data indicate that Ikaros directly contributes to
hug-gene expression mainly by conferring Gata-1
occupancy at hug-promoters (see below) and, together
with Brg1, by stabilizing hug-promoter chromatin
activation.
Ikaros promotes efﬁcient huc-gene transcription
elongation
Here, we show that lack of Ikaros affects TBP and Pol II
recruitment to hug-promoters, and reduces Pol II Ser2
phosphorylation levels. Ikaros can interact with compo-
nents of the basal transcription machinery such as TBP
and TFIIB (67), and with Brg1, which is critical for
long-range chromatin interaction and, such as reported
(60), Pol II transfer. Even though transcription elongation
has been regarded as an important regulatory step for
b-like globin gene regulation (23,68,69), the severe reduc-
tion of Pol II Ser2 phosphorylation levels observed at
hug-promoters in ln2-Ik
null yolk sac EryC was unantici-
pated in light of known properties of Ikaros. Our results
indicate that Ikaros not only participates in PIC assembly
but in addition contributes to Pol II Ser2 phosphorylation
by recruiting the P-TEFb component Cdk9 to hug-gene
promoters.
Cdk9 expression levels increase in terminally
differentiated cells (26). However, in the human
erythroleukemic K562 cell line, Cdk9 knockdown
induces erythroid differentiation (55), whereas erythroid
differentiation of MEL cells does not lead to Cdk942
downregulation and in fact, engenders upregulation of
Cdk955 (28). The reason for these discrepancies is not
known, but it might depend on the intrinsic limitations
of studying erythroid differentiation using transformed
cell lines. Here we show that levels of Cdk9 expression
are very similar in ln2 and ln2-Ik
null yolk sac EryC and
also in yolk sac EryC when compared to fetal liver EryC
(Supplementary Figure S3D). We studied Ikaros-Cdk9
protein interaction in cells expressing predominantly
Cdk942 (yolk sac EryC and COS-7 cells) or both
isoforms (Jurkat cells) and based on our results we
conclude that Ikaros preferentially interacts with Cdk942.
Lack of Ikaros leads to increased and reduced Cdk9
recruitment to HS3 and hug-promoters respectively, and
correlates with reduced long-range chromatin interactions
between the bLCR and the hug-promoters. It is therefore
possible that, as proposed for Pol II (70), Cdk9 ﬁrst accu-
mulates at the bLCR and then, is transferred to the
hug-promoters when the two regulatory regions are in
closer proximity. It is widely accepted that developmental
control of gene expression can be associated with poised
Pol II and the distribution of Pol II across Drosophila and
human genomes have provided evidence that elongation
control might direct the pattern of gene expression during
development (71). In mammalian cells, the P-TEFb
complex accounts for most of Pol II Ser2 phosphorylation
activity (26) and therefore is the best-known activity
capable of reactivating poised Pol II (27). Thus,
Ikaros-dependent Cdk9 transfer to hug-promoters might
be important for the transition from poised Pol II to
productive elongation at the hug-genes.
Recruitment of P-TEFb to highly acetylated gene
promoters can be mediated by the bromodomain
protein Brd4, which interacts directly with CycT1 (27).
However, certain transcription factors, e.g. c-Myc,
CIITA, NF-kB, MyoD, STAT3 and the androgen
receptor can recruit P-TEFb to deﬁned promoter
regions by interacting with either CycT1 or Cdk9
[(26,72) and references herein] and recently Ldb1 has
been shown to recruit P-TEFb to multiple regions of
the mouse b-globin locus (54). Interestingly, GATA-1 is
reported to interact with CYCT1 in a megakaryocyte-like
cell line whereas GATA-1 interaction with CDK9 in the
same cells was not addressed (55). Gata-1 and Cdk9
co-immunoprecipitate in MEL cells but not in COS-7
cells expressing Gata-1 or Gata-1 together with Ikaros,
under the same stringency conditions that allow co-IP of
Ikaros and Cdk9. Thus, it appears that Ikaros can
interact with Cdk9 in several cell lines, whereas Gata-1
interaction with Cdk9 would rather necessitate an eryth-
roid environment. Interestingly, even in absence of a de-
tectable interaction between Gata-1 and Cdk9 in COS-7
cells, the presence of Gata-1 can enhance the strength of
the interaction between Ikaros and Cdk9. Whether the
erythroid-speciﬁc association of Ikaros, Gata-1 and Cdk9
depends upon their relative level of expression or
post-translational modiﬁcations or the presence of
additional erythroid-speciﬁc proteins is thus far
unknown. Nevertheless, it is tempting to assume that
in vivo cooperation between Ikaros and Gata-1 is
designed to facilitate Pol II Ser2 phosphorylation,
possibly by targeting two distinct components of the
P-TEFb complex to hug-gene promoters.
Based on our results, we propose that the recruitment of
Ikaros to hug-promoters in yolk sac EryC, promotes
stable PIC formation and contributes to Cdk9 recruit-
ment, which leads to efﬁcient transcription elongation of
the hug-genes. Therefore, unlike Ldb1-dependent recruit-
ment of P-TEFb that occurs at multiple regions of the
mouse b-globin locus (54), our results suggest that
Ikaros contributes to Cdk9/P-TEFb recruitment speciﬁc-
ally to promoters of the transcriptionally active hug-genes.
According to the observation that Ikaros and Cdk9
co-immunoprecipitate also in lymphoid-like cells
(Figure 7B), it is likely that Ikaros inﬂuences transcription
elongation in a similar manner at other transcriptionally
active Ikaros target genes and in other hematopoietic cells.
In conclusion, we show that Ikaros contributes to efﬁ-
cient transcription initiation and elongation of the
hug-genes in primitive EryC. As such, this study contrib-
utes to a better understanding of the molecular mechan-
isms of Ikaros action to control gene expression in
hematopoietic cells. Therefore, results presented inhere
should provide a basis for understanding malignant
hematopoietic processes characterized by Ikaros- or
GATA-1-dependent gene dysregulation.
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